At the 2015 AATOD Conference, SAMHSA staff and State Opioid Treatment Authorities (SOTAs) convened a day-long meeting to share information and discuss topics of interest to both SAMHSA and the States concerning opioid treatment and regulating Opioid Treatment Programs (OTPs).

AGENDA

Heroin and Prescription Opioids

• Hilary Jacobs (MA): Opioid Crisis in New England
• Mark Fisher (KY): Heroin Addiction in Kentucky
• Cheryl Marcum (MO): Opioid Dependence in Missouri

Mid-Level Practitioners – New Guidance on Exemption Requests

• Melinda Campopiano, MD (SAMHSA): New Federal Guidelines for Opioid Treatment Programs

Performance Measures for MAT/OTP

• Dona Dmitrovic (OptumHealth Behavioral Solutions): Public Health Crisis – A Managed Care Response
• Hilary Jacobs (MA): Data Utilization
• Stacy Chamberlain (KS): Methadone and Managed Care

Health Homes – Primary Care Integration, Rural Treatment Issues

• Susan A. Storti, PhD: Opioid Treatment Program Health Home Initiative
• Yngvild Olsen, MD; Lisa Hadley, MD (MD): Health Homes in Maryland
• Tony Folland (VT): Vermont Hub and Spoke Model for OTPs as Health Homes

Buprenorphine – State Regulation and Oversight

• Brad DeCamp (OH): Expanding Authority for MAT, New Initiatives and Next Steps
• Tony Folland (VT): Buprenorphine in Vermont
• Marc Fishman, MD: Opioid Addiction Treatment – Challenges (and Opportunities) for Community Practice